Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus cath-lab tirofiban in acute myocardial infarction networks
2006-006539-37Phase 3Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tirofiban in myocardial infarction (MI) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoints: Initial TIMI 2-3 flow in the culprit coronary artery and Protocol deviations for tirofiban administration. Started Jan 2007; status: active.
02
Drugs
tirofiban
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2006-006539-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006539-37.